IOVA
Price
$2.27
Change
-$0.00 (-0.00%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
821.41M
51 days until earnings call
TPST
Price
$9.96
Change
-$0.30 (-2.92%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
44.05M
Interact to see
Advertisement

IOVA vs TPST

Header iconIOVA vs TPST Comparison
Open Charts IOVA vs TPSTBanner chart's image
Iovance Biotherapeutics
Price$2.27
Change-$0.00 (-0.00%)
Volume$104.39K
Capitalization821.41M
Tempest Therapeutics
Price$9.96
Change-$0.30 (-2.92%)
Volume$100
Capitalization44.05M
IOVA vs TPST Comparison Chart in %
Loading...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOVA vs. TPST commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (IOVA: $2.27 vs. TPST: $10.26)
Brand notoriety: IOVA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 39% vs. TPST: 57%
Market capitalization -- IOVA: $821.41M vs. TPST: $45.53M
IOVA [@Biotechnology] is valued at $821.41M. TPST’s [@Biotechnology] market capitalization is $45.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • IOVA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both IOVA and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 4 bullish TA indicator(s).

  • IOVA’s TA Score: 4 bullish, 4 bearish.
  • TPST’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than TPST.

Price Growth

IOVA (@Biotechnology) experienced а -4.62% price change this week, while TPST (@Biotechnology) price change was -6.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +6.67%, and the average quarterly price growth was +33.69%.

Reported Earning Dates

IOVA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($821M) has a higher market cap than TPST($44M). TPST YTD gains are higher at: -8.559 vs. IOVA (-69.324). TPST has higher annual earnings (EBITDA): -42.04M vs. IOVA (-364.8M). IOVA has more cash in the bank: 301M vs. TPST (14.3M). TPST has less debt than IOVA: TPST (8.66M) vs IOVA (53.2M). IOVA has higher revenues than TPST: IOVA (242M) vs TPST (0).
IOVATPSTIOVA / TPST
Capitalization821M44M1,866%
EBITDA-364.8M-42.04M868%
Gain YTD-69.324-8.559810%
P/E RatioN/AN/A-
Revenue242M0-
Total Cash301M14.3M2,105%
Total Debt53.2M8.66M614%
FUNDAMENTALS RATINGS
IOVA vs TPST: Fundamental Ratings
IOVA
TPST
OUTLOOK RATING
1..100
7935
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6547
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (23) in the Biotechnology industry is in the same range as TPST (52) in the Pharmaceuticals Major industry. This means that IOVA’s stock grew similarly to TPST’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that IOVA’s stock grew similarly to TPST’s over the last 12 months.

IOVA's SMR Rating (98) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that IOVA’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (47) in the Pharmaceuticals Major industry is in the same range as IOVA (65) in the Biotechnology industry. This means that TPST’s stock grew similarly to IOVA’s over the last 12 months.

TPST's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as IOVA (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOVATPST
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITTX38.62N/A
N/A
MFS Massachusetts Investors Tr A
INSCX24.12N/A
N/A
Catalyst Insider Buying C
RTSAX40.74N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap A
HOOSX30.77N/A
N/A
Hartford Schroders US Small Cap Opps R4
VVMCX17.78N/A
N/A
VALIC Company I Mid Cap Value

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-3.27%
PHIO - TPST
49%
Loosely correlated
-2.29%
ABCZF - TPST
48%
Loosely correlated
N/A
LXEO - TPST
41%
Loosely correlated
+3.86%
ARCT - TPST
40%
Loosely correlated
+4.68%
CRNX - TPST
38%
Loosely correlated
-0.68%
More